Overzicht Proefschriften

Tips in using the search/filter fields

Select on a part of the content: ede	Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes)	Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010	Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011	Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.

Displaying 1-50 of 278 results.

Titel	Promovendus	Promotor 1	Copromotor 1	Copromotor 2	Universiteit	Promotiejaar	Trefwoorden

Treatment response in childhood asthma	Vijverberg S.J.H., PhD	Raaijmakers J.A.M., prof. dr.	Maitland-van der Zee A.H., prof. dr.		Universiteit Utrecht (UU)	2014	Treatment outcomes; Children; Asthma;
Methodological approaches to the pharmacogenomics of statins	Peters B.J.M., dr.	Boer A. de, prof. dr.	Maitland-van der Zee A.H., prof. dr.	Klungel O.H., prof. dr.	Universiteit Utrecht (UU)	2010	Methodology; Statins; Pharmacogenomics;
Towards better treatment outcomes in childhood asthma	Koster E.S., PhD	Raaijmakers J.A.M., prof. dr.	Maitland-van der Zee A.H., prof. dr.		Universiteit Utrecht (UU)	2011	Asthma; Children; Treatment Outcomes; Epidemiology;
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factors	Batenburg W.W., dr.	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2005	Cardiovascular disease; Pharmacology;
Cardiac aldosterone: origin and effects	Chai W., dr.	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2005	Cardiovascular disease; Pharmacology;
Vascular pharmacology of migraine and preeclampsia: Problems of the fair sex	Gupta S., dr.	Saxena P.R., prof. dr.	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.	Erasmus Universiteit Rotterdam (EUR)	2006	Cardiovascular disease; Pharmacology;
Characterization of vascular 5-hydroxytryptamine, adrenergic and CGRP receptors in relation to migraine	Mehrotra S., dr.	Saxena P.R., prof. dr.	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.	Erasmus Universiteit Rotterdam (EUR)	2006	Cardiovascular disease; Pharmacology;
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibition	Esch J.H.M. van, dr.	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2008	Cardiovascular disease; Pharmacology; Renin-angiotensin system;
(Pro)renin revisited: new insights from studies in mast cells	Krop M., dr.	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2009	Cardiovascular disease; Pharmacology; Prorenin;
Natriuretic peptides, diagnostics and prognostic biomarkers	Rutte J.H.W., dr.	Danser A.H.J., prof. dr.	Meiracker A.H. van den, dr.		Erasmus Universiteit Rotterdam (EUR)	2010	Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system;
Neurovascular pharmacology of prospective antimigraine drugs	Chan K.Y., PhD	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.		Erasmus Universiteit Rotterdam (EUR)	2011	Pharmacology; Migraine; Neurovascular pharmacology;
Aortic pathology and the role of the renin-angiotensin system	Molzer E., PhD	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2011	Pharmacology; Cardiovascular disease; Renin-angiotensin system;
The more complex renin-angiotensin system: new insights into an old system	Gembardt F., PhD	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2011	Pharmacology; Renin-angiotensin system;
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approach	Kappers M.H.W., PhD	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2011	Cancer; Pharmacology; Antihypertensive drugs;
Vascular aging from DNA damage to protection	Ďurik M., PhD	Danser A.H.J., prof. dr.	Roks A.J.M., dr.		Erasmus Universiteit Rotterdam (EUR)	2012	Cardiovascular disease; Pharmacology;
The role of aldosterone and aldosterone blockade in hypertension	Jansen P.M., PhD	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2013	Cardiovascular disease; Antihypertensive drugs; Pharmacology;
Neurovascular pharmacology of migraine: epigenetics and sex hormones	Labruijere S., PhD	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.		Erasmus Universiteit Rotterdam (EUR)	2014	Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology;
Novel directions in therapy against age-related vascular disease	Wu H., PhD	Danser A.H.J., prof. dr.	Roks A.J.M., dr.		Erasmus Universiteit Rotterdam (EUR)	2014	Pharmacology; Cardiovascular disease;
The alternative renin-angiotensin system: exploration of its therapeutic potential	Sevá Pessôa B., PhD	Danser A.H.J., prof. dr.	Roks A.J.M., dr.		Erasmus Universiteit Rotterdam (EUR)	2015	Pharmacology; Cardiovascular disease; Renin-angiotensin system;
The (pro)renin receptor: moving away from prorenin?	Lu X., PhD	Danser A.H.J., prof. dr.	Meima M.E., dr.		Erasmus Universiteit Rotterdam (EUR)	2014	Cardiovascular disease; Pharmacology; Prorenin;
Preeclampsia, the renin-angiotensin-aldosterone system and beyond	Verdonk K., PhD	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2015	Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system;
Driving-impairing medicines and traffic safety: patients' perspectives	Monteiro S.P., PhD	Gier J.J. de, prof. dr.	Dijk C.E.M.J. van, dr. ir.		Rijksuniversiteit Groningen (RUG)	2014
Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions	Hasselt F.M. van, PhD	Loonen A.J.M., prof. dr.	Oud M.J.T., dr.	Krabbe P.F.M., dr.	Rijksuniversiteit Groningen (RUG)	2013
The therapeutic potential of Indoleamine 2.3-dioxygenase in kidney transplantation	Vavrinacova-Yaghi D., PhD	Henning R.H., prof. dr.	Sandovici M., dr.	Seelen M.A.J., dr.	Rijksuniversiteit Groningen (RUG)	2014	Pharmacology; kidney transplantation Indoleamine 2.3-dioxygenase
Cognition in Huntington's disease : the influence of motor behaviour and time	Hart E.P. 't, PhD	Roos R.A.C., prof. dr.			Universiteit Leiden (UL)	2013	Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour
HIV treatment: a clinical pharmacology perspective	Luin M. van, dr.	Hekster Y.A., prof. dr.	Burger D.M., prof. dr.	Richter C., dr.	Radboud Universiteit (RU)	2010	Clinical pharmacology; Pharmacokinetics; HIV; Therapeutic drug monitoring; drug-drug interactions; antiretroviral drugs
Optmizing long-term care for hiv-infected patients in Thailand	Ramautarsing R.A., PhD	Burger D.M., prof. dr.	Wit F.W.N.M., dr.	Wijgert J.H.H.M. van de, dr.	Universiteit van Amsterdam (UvA)	2013	HIV; clinical pharmacology
Optimizing protease inhibitor-based antiretroviral therapy for HIV-1 infected Thai adults and children	Lugt J. van der, dr.	Lange J.M.A., prof. dr.	Ananworanich J., dr.	Burger D.M., prof. dr.	Universiteit van Amsterdam (UvA)	2010	Antiretroviral; HIV; Pharmacokinetics; Clinical pharmacology; therapeutic drug monitoring
Clinical pharmacological studies in tuberculosis patients	Semvua H.H., PhD	Burger D.M., prof. dr.	Aarnoutse R.E., dr.	Boeree M.J., dr.	Radboud Universiteit (RU)	2014	Clinical pharmacology; Pharmacokinetics; Tuberculosis
The role of efflux and influx transporters in the disposition of digitalis-like compounds	Gozalpour E., PhD	Russel F.G.M., prof. dr.			Radboud Universiteit (RU)	2015
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and disease	Weigand K.M., PhD	Russel F.G.M., prof. dr.			Radboud Universiteit (RU)	2015
Loss of proteostasis as a substrate for Atrial Fibrilation.	Meijering R.A.M., PhD	Henning R.H., prof. dr.	Brundel B.J.J.M., dr.		Rijksuniversiteit Groningen (RUG)	2014	Atrial fibrillation; Proteostasis;
Optimizing cancer therapy. A focus on molecular imaging	Gaykema S.B.M., PhD	Vries E.G.E. de, prof. dr.		Lub-de Hooge M.N., dr.	Rijksuniversiteit Groningen (RUG)	2014
Preclinical targeting of the tumor microenvironment. Possibilities and consequences	Arjaans M., PhD	Vries E.G.E. de, prof. dr.	Schröder C.P., dr.	Timmer-Bosscha H., dr.	Rijksuniversiteit Groningen (RUG)	2015
The role of endogenous H2S production during hybernation and forced hypothermia: towards safe cooling and rewarming in clinical practice	Dugbartey G.J., PhD	Henning R.H., prof. dr.	Bouma H.R., PhD		Rijksuniversiteit Groningen (RUG)	2015
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation	Wiersma M., PhD	Henning R.H., prof. dr.	Brundel B.J.J.M., dr.		Rijksuniversiteit Groningen (RUG)	2016	Atrial fibrillation;
End-organ damage in diabetes: exploring innovative targets and therapies	Hamidi M., PhD	Henning R.H., prof. dr.	Buikema J.H., dr.	Deelman L.E., dr.	Rijksuniversiteit Groningen (RUG)	2015	Diabetes mellitus;
Biomarkers as assessment of drug efficacy in cardiovascular disease	Smink P.A., PhD	Zeeuw D. de, prof. dr.	Lambers Heerspink H.J., prof. dr.	Bakker S.J.L., prof. dr.	Rijksuniversiteit Groningen (RUG)	2013	cardiovascular disease biomarkers drug efficacy
Novel protective approaches in ischemia-reperfusion injury. In vivo studies in animals and humans	Wever K.E., PhD	Rongen G.A., prof. dr.	Masereeuw R., prof. dr.	Warlé M.C., dr.	Radboud Universiteit (RU)	2012	Renal, ischemia/reperfusion injury, remote ischemic preconditioning, Annexin A5, animal and human research
Risk factors and treatment of paediatric chronic diseases - Type 1 diabetes, asthma and allergy	Ahmadizar F., PhD	Boer A. de, prof. dr.	Maitland-van der Zee A.H., prof. dr.		Universiteit Utrecht (UU)	2016	Children; Diabetes mellitus; Allergy
Intranasal drug delivery in migraine	Kuy P.H.M. van der, dr.	Merkus F.W.H.M., prof. dr.	Lohman J.J.H.M., dr.		Universiteit Leiden (UL)	2003	Migraine; Intranasal
COMPARE: Care in Oncolytic Medication surveillance:Pharmacovigilance, Acceptability, Risks and Events	Oijen B.P.C. van, dr.	Schouten H.C., prof. dr.	Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD	Universiteit Maastricht (UM)	2015	Chemotherapy; Clinical pharmacology; Pharmaceutical care;
Medication surveillance in older patients : clinical decision support as the next step in medication safety	Hurkens K.P.M.G., MD PhD MBA	Stehouwer C.D.A., prof. dr.	Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD	Universiteit Maastricht (UM)	2013	Clinical pharmacology; Elderly; clinical rules
Medication Optimization; exploring the use of a clinical decision support system	Wit H.A.J.M. de, PhD	Schols J.M.G.A., prof. dr.	Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD	Universiteit Maastricht (UM)	2016	Clinical pharmacology; Clinical rules; CDSS
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too little	Colbers E.P.H., PhD	Burger D.M., prof. dr.			Radboud Universiteit (RU)	2015	HIV; antiretroviral agents; clinical pharmacology; drug drug interactions
Pharmaceutical development, preclinical research and clinical application of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDP	Lange R., PhD	Hendrikse N.H., prof. dr.	Heine R. ter, dr.	Bloemendal H.J., dr.	Vrije Universiteit Amsterdam (VU)	2017	Radiopharmaceutics; Pharmaceutical development; Rhenium;
Unintended effects of anti-hyperglycaemic drugs studied in population-based cohorts	Driessen J.H.M., PhD	Bergh J.P.W. van den, prof. dr.	Vries F. de, prof. dr.	Onzenoort H.A.W. van, PhD	Universiteit Maastricht (UM)	2017	Hyperglycaemic drugs; Population-based;
Making things easier: how to improve antiviral drug treatment for children	Bastiaans D.E.T., dr.	Burger D.M., prof. dr.			Radboud Universiteit (RU)	2016	Clinical pharmacology; Antiviral drug treatment;
Thermopharmacology of anticonvulsive treatment after perinatal asphyxia	Broek M.P.H. van den, PhD	Egberts A.C.G., prof. dr.	Rademaker C.M.A., dr.		Universiteit Utrecht (UU)	2013	PK-PD modelling; Newborns; Thermopharmacology; Convulsions;
Pharmacokinetics, pharmacodynamics and safety of different propofol formulations	Knibbe C.A.J., prof. dr.	Danhof M., prof. dr.	Aarts L.P.H.J., prof. dr.	Kuks P.F.M., dr.	Universiteit Leiden (UL)	2002	Pharmacokinetics; Pharmacodynamics; Propofol;